Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer

OBJECTIVES: To investigate whether radiotherapy as metastasis-directed therapy (MDT) on oligo-progressive sites in metastatic castration-resistant prostate cancer (mCRPC) patients during treatment with androgen receptor-targeted therapy (ARTT) may lead to control resistant lesions, prolonging ARTT....

Descripción completa

Detalles Bibliográficos
Autores principales: Massaro, Maria, Facondo, Giuseppe, Vullo, Gianluca, Aschelter, Anna Maria, Rossi, Alessandro, De Sanctis, Vitaliana, Marchetti, Paolo, Osti, Mattia Falchetto, Valeriani, Maurizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495216/
https://www.ncbi.nlm.nih.gov/pubmed/34631527
http://dx.doi.org/10.3389/fonc.2021.695136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495216/
https://www.ncbi.nlm.nih.gov/pubmed/34631527
http://dx.doi.org/10.3389/fonc.2021.695136

Ejemplares similares